EUVIMEDEUVIMED entdecken
Crossref

Sishen Pill & Tongxieyaofang ameliorated ulcerative colitis through the activation of HIF-1α acetylation by gut microbiota-derived propionate and butyrate

Haifan Liu, Dunfang Wang, Xue Feng, Li Liu, Bin Liu, Lin Zhu, Jingwei Sun, Xingbo Zuo, Siyuan Chen, Junying Xian, Caijuan Zhang, Weipeng Yang

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2024.156264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Haifan Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, Hypoxia-Inducible Factor 1, alpha Subunit, Drugs, Chinese Herbal. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Academy of Chinese Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease closely related to gut microbiota dysbiosis and intestinal homeostasis imbalance. Sishen Pill&Tongxieyaofang (SSP-TXYF) has a long history of application in traditional Chinese medicine and is widely used in UC clinics. However, its mechanism of action is still unclear. PURPOSE: This study aimed to explore the potential regulatory role of SSP-TXYF in protecting against UC through metabolites produced by the intestinal microbiota, and elucidate its underlying molecular mechanism. STUDY DESIGN AND METHODS: 16S rRNA and UPLC-QE-Orbitrap-MS were used to assess the microbiota and short-chain fatty acids (SCFAs). A rat model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced gut microbiota dysbiosis was used to study the effects of SSP-TXYF on UC in vivo. Intestinal epithelial cells-6 (IEC-6) were treated with lipopolysaccharide (LPS). The intestinal mucosal barrier (IMB) functions were investigated by alcian blue staining and western blot analysis. The mechanism of SSP-TXYF influenced the HIF-1α acetylation pathway was examined by real-time fluorescence quantitative PCR (qPCR), Western blotting, and Co-immunoprecipitation. RESULTS: Using 16S rRNA gene-based microbiota analysis, we found that SSP-TXYF ameliorated TNBS-induced gut microbiota dysbiosis. We found that SSP-TXYF significantly inhibited the decreased abundance of Firmicutes in UC rats, in addition, the abundance of Actinobacteria was also improved. The mechanism of SSP-TXYF-treated TNBS-induced UC resulted from improved IMB functions via the activation of hypoxia-inducible factor-1 (HIF-1α) acetylation. Notably, SSP-TXYF Enriched microbiota-derived metabolites propionate and butyrate, which could activate HIF-1α acetylation in IEC. Furthermore, exogenous treatment of propionate and butyrate reproduced similar protective effects as SSP-TXYF to UC through improving HIF-1α-dependent IMB functions. CONCLUSIONS: Overall, our findings suggest that the gut microbiota-propionate/butyrate-HIF-1α-IMB axis plays an important role in SSP-TXYF-maintaining intestinal homeostasis, which may represent a novel approach for UC prevention via the intervention of any link in this axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeGastrointestinal MicrobiomeHypoxia-Inducible Factor 1, alpha SubunitDrugs, Chinese HerbalButyratesPropionatesAnimalsMaleRats, Sprague-DawleyRatsAcetylationTrinitrobenzenesulfonic AcidIntestinal MucosaDysbiosisFatty Acids, VolatileDisease Models, Animal

Stichwörter der Autor:innen

Gut microbiotaHIF-1αIntestinal mucosal barrierShort chain fatty acidSishen Pill&TongxieyaofangUlcerative colitis

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitDrugs, Chinese HerbalButyratesTrinitrobenzenesulfonic AcidPropionatesHif1a protein, ratFatty Acids, Volatile

Autor:innen und Institutionen

  • Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
  • Beijing University of Chinese Medicine, Beijing, China.
  • Heilongjiang University of Chinese Medicine, Harbin, China.
  • Nanning Hospital of Traditional Chinese Medicine, Nanning, China.
  • Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: cjzhang@icmm.ac.cn.
  • Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: hrbywp@sina.com.

Förderung

  • National Natural Science Foundation of China
  • China Academy of Chinese Medical Sciences

Zitieren

APA

Liu, H., Wang, D., Feng, X., Liu, L., Liu, B., Zhu, L., Sun, J., Zuo, X., Chen, S., Xian, J., Zhang, C., & Yang, W. (2025). Sishen Pill & Tongxieyaofang ameliorated ulcerative colitis through the activation of HIF-1α acetylation by gut microbiota-derived propionate and butyrate. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.156264

Vancouver

Liu H, Wang D, Feng X, Liu L, Liu B, Zhu L, et al. Sishen Pill & Tongxieyaofang ameliorated ulcerative colitis through the activation of HIF-1α acetylation by gut microbiota-derived propionate and butyrate. Phytomedicine. 2025. doi:10.1016/j.phymed.2024.156264

BibTeX
@article{Liu2025,
  author = {Liu, Haifan and Wang, Dunfang and Feng, Xue and Liu, Li and Liu, Bin and Zhu, Lin and Sun, Jingwei and Zuo, Xingbo and Chen, Siyuan and Xian, Junying and Zhang, Caijuan and Yang, Weipeng},
  title = {Sishen Pill & Tongxieyaofang ameliorated ulcerative colitis through the activation of HIF-1α acetylation by gut microbiota-derived propionate and butyrate},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2024.156264}
}
Kostenlos starten →